Integra Lifesciences Holdings (IART) Receivables (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Receivables of $267.2 million for Q2 2026, up 1.05% sequentially from $264.4 million in Q1 2026, and down 6.09% YoY from $284.5 million in Q2 2025.
Integra Lifesciences Holdings (IART) Receivables (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Receivables for 18 years, with the latest figure at $267.2 million in Q2 2026.
- Quarterly Receivables fell 6.09% year-over-year to $267.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $267.2 million (down 6.09% YoY) and the FY2025 annual result came in at $278.8 million, up 2.38% from the prior year.
- Receivables improved to $267.2 million in Q2 2026 per IART's latest filing, from $264.4 million in the prior quarter.
- Over five years, Receivables peaked at $284.5 million in Q2 2025 and troughed at $234.0 million in Q1 2022.
- A 5-year average of $258.5 million and a median of $259.0 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2026: Receivables grew 13.65% in 2022, then fell 6.09% in 2026.
- Over 5 years, Receivables stood at $263.5 million in 2022, then slipped by 1.57% to $259.3 million in 2023, then rose by 5.03% to $272.4 million in 2024, then grew by 2.38% to $278.8 million in 2025, then declined by 4.18% to $267.2 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $267.2 million, $264.4 million, and $278.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.58 Bn | 196.98 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 126.47 Bn | 122.99 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.27 Bn | 110.05 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.64 Bn | 47.39 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 35.03 Bn | 33.09 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 267.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 267.19 Mn |
| Mar 31, 2026 | 264.41 Mn |
| Dec 31, 2025 | 278.85 Mn |
| Sep 30, 2025 | 262.16 Mn |
| Jun 30, 2025 | 284.51 Mn |
| Mar 31, 2025 | 252.45 Mn |
| Dec 31, 2024 | 272.37 Mn |
| Sep 30, 2024 | 248.30 Mn |
| Jun 30, 2024 | 271.16 Mn |
| Mar 31, 2024 | 241.09 Mn |
| Dec 31, 2023 | 259.33 Mn |
| Sep 30, 2023 | 256.27 Mn |
| Jun 30, 2023 | 258.66 Mn |
| Mar 31, 2023 | 254.00 Mn |
| Dec 31, 2022 | 263.47 Mn |
| Sep 30, 2022 | 248.27 Mn |
| Jun 30, 2022 | 237.36 Mn |
| Mar 31, 2022 | 234.01 Mn |
| Dec 31, 2021 | 231.83 Mn |
| Sep 30, 2021 | 222.23 Mn |